Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Califf

Showing results (11-20 of 567) with videos related to

Pageof 57
Sort By:
American Heart Journal|September 30, 2000
Genetics, genomics, proteomics: what is a cardiologist to do?R M Califf
American Heart Journal|April 30, 1999
Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Evaluating the economic implications of cardiovascular therapeuticsR M Califf
American Heart Journal|March 31, 1999
What to do with acute atrial fibrillation?R M Califf
European Heart Journal|September 1, 1996
The rationale for thrombolytic therapyR M Califf
Cardiology Clinics|August 1, 1995
How should clinicians interpret clinical trials?R M Califf
American Heart Journal|September 1, 1995
Restenosis: the cost to societyR M Califf
The Medical Clinics of North America|September 1, 1995
Acute ischemic syndromesR M Califf
European Heart Journal|February 8, 2003
Cardiac markers in acute coronary syndromes-refining our knowledgeR M Califf
Journal of the American College of Cardiology|April 1, 1989
Myocardial reperfusion: is it ever too late?R M Califf
The American Journal of Cardiology|September 11, 1998
Robert McKinnon Califf, MD: a conversation with the editor. Interview by William Clifford RobertsR M Califf
Pageof 57

Showing results (11-20 of 567) with videos related to

Sort By:
Pageof 57
American Heart Journal|September 30, 2000
Genetics, genomics, proteomics: what is a cardiologist to do?R M Califf
American Heart Journal|April 30, 1999
Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Evaluating the economic implications of cardiovascular therapeuticsR M Califf
American Heart Journal|March 31, 1999
What to do with acute atrial fibrillation?R M Califf
European Heart Journal|September 1, 1996
The rationale for thrombolytic therapyR M Califf
Cardiology Clinics|August 1, 1995
How should clinicians interpret clinical trials?R M Califf
American Heart Journal|September 1, 1995
Restenosis: the cost to societyR M Califf
The Medical Clinics of North America|September 1, 1995
Acute ischemic syndromesR M Califf
European Heart Journal|February 8, 2003
Cardiac markers in acute coronary syndromes-refining our knowledgeR M Califf
Journal of the American College of Cardiology|April 1, 1989
Myocardial reperfusion: is it ever too late?R M Califf
The American Journal of Cardiology|September 11, 1998
Robert McKinnon Califf, MD: a conversation with the editor. Interview by William Clifford RobertsR M Califf
Pageof 57